Clinical

Dataset Information

0

A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study


ABSTRACT: This was a multicenter, open-label extension study. Patients who received vismodegib (GDC-0449) in a Genentech-sponsored study and who had completed the parent study or who continued to receive vismodegib at the time the parent study closed were eligible for continued treatment in this protocol.

DISEASE(S): Ovarian Cancer,Metastatic Colorectal Cancer,Carcinoma, Basal Cell,Basal Cell Carcinoma

PROVIDER: 2076702 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2017-02-03 | GSE94239 | GEO
2019-04-22 | GSE123807 | GEO
| 2104692 | ecrin-mdr-crc
2024-04-15 | GSE264049 | GEO
2020-01-24 | GSE139178 | GEO
| 2011794 | ecrin-mdr-crc
2010-06-08 | E-GEOD-20719 | biostudies-arrayexpress
2018-10-01 | GSE108464 | GEO
| 2301010 | ecrin-mdr-crc
2017-10-27 | MSV000081651 | MassIVE